Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00004217. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Safety, Pharmacokinetics and Pharmacodynamics of TKI258 in Subjects With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00279773. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Acute Myeloid Leukemia Registry
ClinicalTrials.gov study NCT05979675. IPD Sharing: NO. Countries: 1. Publications: 2.
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
ClinicalTrials.gov study NCT02115295. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00003190. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Extramedullary Acute Myeloid Leukemia (eAML): Retrospective Single Center Cohort Study, Clinicopathological, Molecular Analysis and Survival Outcomes
ClinicalTrials.gov study NCT05057299. IPD Sharing: NO. Countries: 1. Publications: 2.
Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT02544438. IPD Sharing: Not stated. Countries: 1. Publications: 1.
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00151255. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Daunorubicin Hydrochloride, Cytarabine and Oblimersen Sodium in Treating Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00085124. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06497062. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
ClinicalTrials.gov study NCT00689000. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02056782. IPD Sharing: UNDECIDED. Countries: 0. Publications: 28.
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04107727. IPD Sharing: NO. Countries: 1. Publications: 1.
Oral Clofarabine for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00727766. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Autologous Hematopoietic Cell Transplantation for Core-binding Factor Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01050036. IPD Sharing: NO. Countries: 1. Publications: 33.
Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00028899. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Pilot Clinical Trial of Pazopanib in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When no Intensive Treatment is Possible
ClinicalTrials.gov study NCT01361334. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04336982. IPD Sharing: YES. Countries: 5. Publications: 1.
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00516828. IPD Sharing: NO. Countries: 1. Publications: 0.
Cusatuzumab in Combination With Background Therapy for the Treatment of Participants With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04150887. IPD Sharing: YES. Countries: 5. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.